Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04581382 |
|---|---|
| Brief Title: | Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma |
| First Submitted : | September 18, 2020 |
| First Submitted that Met QC Criteria : | October 5, 2020 |
| First Posted : | October 9, 2020 |
| Last Update Submitted that Met QC Criteria : | June 15, 2021 |
| Last Update Posted : | June 21, 2021 |